Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 144
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from...
Jaguar Health and Filament Health, with Funding from One Small Planet,...
Bright Minds Biosciences Announces Resignation of Board Member
Psychedelic Research Bulletin: December 2022
Optimi Health Announces Re-Appointments to Board of Directors
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for...
PT381 – DMT, Hierarchies of Complexity, and Reality Switch Technologies
Load more
